CLINICAL_TRIALS
trial_result
· 2017-01-27
Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone [Phase 3]
Summary
This completed Phase 3 trial evaluated the efficacy and safety of insulin detemir added to oral hypoglycemic therapy in adults with type 2 diabetes inadequately…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED